Actively Recruiting
Liposomal Bupivacaine vs Ropivacaine for TAPBs
Led by Sun Yat-sen University · Updated on 2024-05-28
74
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Few studies have compared the efficacy of ultrasound (US)-guided TAP blocks with Liposomal bupivacaine(LB) versus ropivacaine in reducing postoperative opioid usage in patients undergoing laparoscopic lower abdominal tumor Resection. Therefore, we are conducting this prospective, randomized controlled trial to compare the postoperative analgesic effects of LB and ropivacaine for TAP blocks among patients undergoing laparoscopic colorectal procedures.
CONDITIONS
Official Title
Liposomal Bupivacaine vs Ropivacaine for TAPBs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing laparoscopic resection of lower abdominal tumors
- ASA grade II-III
- Age 18 to 70 years
You will not qualify if you...
- Patient does not agree to participate in the clinical study
- History of opioid tolerance or allergy
- History of local anesthetic allergy
- History of dementia, mental illness, or other central nervous system diseases
- History of chronic pain or current use of opioids or other analgesics
- Poor general condition with serious cardiovascular, respiratory, digestive, urinary, or central nervous system diseases with life expectancy less than 3 months
- History within 12 months before surgery of myocardial infarction, severe or unstable angina, coronary artery bypass grafting, congestive heart failure, cerebrovascular accident, or pulmonary embolism
- Pregnant women
- Unable to cooperate with follow-up or poor compliance
- Acute myocardial infarction, cardiac arrest, or shock during surgery or hospitalization
- ASA score above grade III
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Jingdun Xie
Guangzhou, Guangdong, China, 510060
Actively Recruiting
Research Team
P
Ping Yu
CONTACT
J
Jingdun Xie
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here